Gianni Marone

Q: What Schools Are Affiliated With Gianni Marone

Gianni Marone is affiliated with the following schools: University of California, Berkeley, Stanford University, Johns Hopkins University, University of Naples Federico II

Gianni Marone's AcademicInfluence.com Rankings

Gianni Marone

Computer Science

#5256

World Rank

#5551

Historical Rank

Computational Linguistics

#689

World Rank

#701

Historical Rank

Machine Learning

#1320

World Rank

#1340

Historical Rank

Artificial Intelligence

#1559

World Rank

#1588

Historical Rank

computer-science Degrees

Download Badge

Computer Science

Gianni Marone's Degrees

Masters Artificial Intelligence Stanford University
Bachelors Computer Science University of California, Berkeley

Similar Degrees You Can Earn

Why Is Gianni Marone Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Gianni Marone's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tumor associated macrophages and neutrophils in tumor progression (2013) (356)
Risk assessment in anaphylaxis: current and future approaches. (2007) (275)
Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines. (1999) (234)
Stem cell factor in mast cells and increased mast cell density in idiopathic and ischemic cardiomyopathy. (1998) (231)
Are Mast Cells MASTers in Cancer? (2017) (223)
Are Mast Cells MASTers in Cancer? (2017) (223)
Cardiotoxicity of immune checkpoint inhibitors (2017) (204)
Cardiotoxicity of immune checkpoint inhibitors (2017) (204)
The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements (2016) (188)
Mast cells have a protumorigenic role in human thyroid cancer (2010) (184)
Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects. (2009) (182)
Human heart mast cells. Isolation, purification, ultrastructure, and immunologic characterization. (1995) (176)
Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8–Akt–Slug pathway (2015) (159)
A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group. (1993) (154)
Effects of arachidonic acid and its metabolites on antigen-induced histamine release from human basophils in vitro. (1979) (153)
Activation of Cytokine Production by Secreted Phospholipase A2 in Human Lung Macrophages Expressing the M-Type Receptor1 (2005) (151)
Eosinophils: The unsung heroes in cancer? (2018) (148)
Eosinophils: The unsung heroes in cancer? (2018) (148)
Allergy and the cardiovascular system (2008) (146)
Adenosine potentiates mediator release from human lung mast cells. (1988) (142)
Anti-inflammatory effect of FK-506 on human skin mast cells. (1992) (141)
Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin. (1990) (141)
Cancer Inflammation and Cytokines. (2018) (140)
Anti-inflammatory effect of cyclosporin A on human skin mast cells. (1992) (139)
Histamine Induces Exocytosis and IL-6 Production from Human Lung Macrophages Through Interaction with H1 Receptors1 (2001) (138)
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor. (1994) (135)
HIV-1 gp120 Induces IL-4 and IL-13 Release from Human FcεRI+ Cells Through Interaction with the VH3 Region of IgE1 (2000) (134)
Molecular basis for the lack of HERG K+ channel block-related cardiotoxicity by the H1 receptor blocker cetirizine compared with other second-generation antihistamines. (1998) (133)
Occurrence and significance of tumor‐associated neutrophils in patients with colorectal cancer (2016) (132)
Expression and Functions of the Vascular Endothelial Growth Factors and Their Receptors in Human Basophils1 (2006) (132)
Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer (2016) (128)
Angiogenesis and lymphangiogenesis in inflammatory skin disorders. (2015) (127)
Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes. (2005) (125)
Molecular and cellular biology of mast cells and basophils. (1997) (124)
Mast cells and basophils: friends as well as foes in bronchial asthma? (2005) (123)
Angiogenesis and lymphangiogenesis in bronchial asthma (2010) (120)
FK-506, a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells. (1991) (119)
Mast Cells, Angiogenesis and Lymphangiogenesis in Human Gastric Cancer (2019) (118)
Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer (2018) (117)
Characterization of a specific adenosine receptor on human lymphocytes. (1978) (117)
Thymic Stromal Lymphopoietin Isoforms, Inflammatory Disorders, and Cancer (2018) (117)
Immune and Inflammatory Cells in Thyroid Cancer Microenvironment (2019) (116)
Pure Red Cell Aplasia: Studies on an IgG Serum Inhibitor Neutralizing Erythropoietin (1975) (113)
Urokinase Induces Basophil Chemotaxis through a Urokinase Receptor Epitope That Is an Endogenous Ligand for Formyl Peptide Receptor-Like 1 and -Like 21 (2004) (111)
Human basophil/mast cell releasability. IX. Heterogeneity of the effects of opioids on mediator release. (1992) (109)
Eosinophil granule proteins activate human heart mast cells. (1996) (109)
Stem cell factor is localized in, released from, and cleaved by human mast cells. (1999) (108)
Production of Vascular Endothelial Growth Factors from Human Lung Macrophages Induced by Group IIA and Group X Secreted Phospholipases A2 (2010) (108)
Activation of human inflammatory cells by secreted phospholipases A2. (2006) (106)
Antineoplastic Drug-Induced Cardiotoxicity: A Redox Perspective (2018) (101)
Immunological characterization and functional importance of human heart mast cells. (1995) (100)
Probing the roles of mast cells and basophils in natural and acquired immunity, physiology and disease. (2002) (100)
Migration of human inflammatory cells into the lung results in the remodeling of arachidonic acid into a triglyceride pool (1995) (100)
Roles of neutrophils in cancer growth and progression (2017) (97)
Bacterial Immunoglobulin Superantigen Proteins A and L Activate Human Heart Mast Cells by Interacting with Immunoglobulin E (2000) (96)
European allergy white paper: allergic diseases as a public health problem in Europe (1997) (95)
Immune Checkpoint Inhibitors and Cardiac Toxicity: An Emerging Issue. (2018) (93)
Mast cells and basophils in inflammatory and tumor angiogenesis and lymphangiogenesis. (2016) (93)
Human lung‐resident macrophages express CB1 and CB2 receptors whose activation inhibits the release of angiogenic and lymphangiogenic factors (2016) (93)
Functional heterogeneity of human mast cells from different anatomic sites: in vitro responses to morphine sulfate. (1987) (92)
Secretory Phospholipases A2 Induce β-Glucuronidase Release and IL-6 Production from Human Lung Macrophages1 (2000) (91)
IgG anti-IgE from atopic dermatitis induces mediator release from basophils and mast cells. (1989) (91)
Human basophil/mast cell releasability. V. Functional comparisons of cells obtained from peripheral blood, lung parenchyma, and bronchoalveolar lavage in asthmatics. (1989) (91)
Immunoglobulin Superantigen Protein L Induces IL-4 and IL-13 Secretion from Human FcεRI+ Cells Through Interaction with the κ Light Chains of IgE 1 (2003) (90)
Neuro-Endocrine Networks Controlling Immune System in Health and Disease (2014) (90)
The role of agonists that activate adenylate cyclase in the control of cAMP metabolism and enzyme release by human polymorphonuclear leukocytes. (1980) (90)
Human mast cells and basophils—How are they similar how are they different? (2018) (89)
Effect of activation of the H1 receptor on coronary hemodynamics in man. (1986) (88)
Adenosine receptor on human basophils: modulation of histamine release. (1979) (87)
Protein L. A bacterial Ig-binding protein that activates human basophils and mast cells. (1990) (86)
Formyl peptide receptors at the interface of inflammation, angiogenesis and tumor growth. (2015) (85)
Endogenous superallergen protein Fv induces IL-4 secretion from human Fc epsilon RI+ cells through interaction with the VH3 region of IgE. (1998) (85)
Human synovial mast cells. I. Ultrastructural in situ and in vitro immunologic characterization. (1996) (85)
Human heart mast cells: a definitive case of mast cell heterogeneity. (1995) (83)
Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer (2017) (81)
Bidirectional Mast Cell–Eosinophil Interactions in Inflammatory Disorders and Cancer (2017) (81)
The histamine-cytokine network in allergic inflammation. (2003) (80)
Heterogeneity of human mast cells and basophils in response to muscle relaxants. (1991) (79)
Innate effector cells in angiogenesis and lymphangiogenesis. (2018) (79)
Innate effector cells in angiogenesis and lymphangiogenesis. (2018) (79)
Human basophil releasability. I. Age-related changes in basophil releasability. (1986) (78)
Expression of the Chemokine Receptor CCR3 on Human Mast Cells (2001) (78)
The Intriguing Role of Interleukin 13 in the Pathophysiology of Asthma (2019) (76)
Characterization of the anti-inflammatory effect of FK-506 on human mast cells. (1991) (76)
T follicular helper (Tfh) cells in normal immune responses and in allergic disorders (2016) (75)
Tat Protein Is an HIV-1-Encoded β-Chemokine Homolog That Promotes Migration and Up-Regulates CCR3 Expression on Human FcεRI+ Cells1 (2000) (75)
Cardiovascular Effects of Histamine Infusion in Man (1983) (73)
Inhibition of IgE-mediated release of histamine and peptide leukotriene from human basophils and mast cells by forskolin. (1987) (73)
Basophils Infiltrate Human Gastric Mucosa at Sites of Helicobacter pylori Infection, and Exhibit Chemotaxis in Response to H. pylori-derived Peptide Hp(2–20)1 (2004) (73)
The immune network in thyroid cancer (2016) (72)
Human skin mast cells express functional beta 1 integrins that mediate adhesion to extracellular matrix proteins. (1995) (72)
The balance between pro‐ and anti‐inflammatory cytokines is crucial in human allergic contact dermatitis pathogenesis: the role of IL‐1 family members (2013) (72)
VEGF-A in Cardiomyocytes and Heart Diseases (2020) (72)
The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis (2014) (72)
Human basophil/mast cell releasability. XI. Heterogeneity of the effects of contrast media on mediator release. (1996) (71)
Signaling events involved in cytokine and chemokine production induced by secretory phospholipase A2 in human lung macrophages (2006) (71)
Inhibition of histamine and prostaglandin D2 release from human lung mast cells by ciclosporin A. (1989) (70)
Human basophil releasability. II. Changes in basophil releasability in patients with atopic dermatitis. (1986) (70)
Cyclosporin H is a potent and selective competitive antagonist of human basophil activation by N-formyl-methionyl-leucyl-phenylalanine. (1996) (69)
Future Needs in Mast Cell Biology (2019) (69)
IgE-mediated histamine release from human basophils: differences between antigen E- and anti-IgE-induced secretion. (1981) (69)
Asthma: recent advances. (1998) (69)
Role of mast cells, basophils and their mediators in adverse reactions to general anesthetics and radiocontrast media. (1996) (68)
Mechanisms of activation of human mast cells and basophils by general anesthetic drugs. (1993) (68)
Cardiac ion channels and antihistamines: possible mechanisms of cardiotoxicity (1999) (67)
Role of human mast cells and basophils in bronchial asthma. (2005) (67)
Autoimmune Endocrine Dysfunctions Associated with Cancer Immunotherapies (2019) (66)
The Pleiotropic Immunomodulatory Functions of IL-33 and Its Implications in Tumor Immunity (2018) (66)
Nasal allergen‐neutralizing IgG4 antibodies block IgE‐mediated responses: Novel biomarker of subcutaneous grass pollen immunotherapy (2019) (65)
Secretory phospholipases A2 induce cytokine release from blood and synovial fluid monocytes (2002) (65)
Physiological Roles of Mast Cells: Collegium Internationale Allergologicum Update 2019 (2019) (62)
Differentiation of monocytes into macrophages induces the upregulation of histamine H1 receptor. (2007) (61)
Secretory Phospholipases A2 Activate Selective Functions in Human Eosinophils1 (2003) (61)
Heterogeneity of Human Mast Cells With Respect to MRGPRX2 Receptor Expression and Function (2019) (60)
Controversial role of mast cells in skin cancers (2017) (59)
Controversial role of mast cells in skin cancers (2017) (59)
Differential roles for triglyceride and phospholipid pools of arachidonic acid in human lung macrophages. (1994) (58)
Characterization of platelet-activating factor acetylhydrolase in human bronchoalveolar lavage. (1997) (57)
Tezepelumab: a novel biological therapy for the treatment of severe uncontrolled asthma (2019) (57)
Human basophil releasability. VI. Changes in basophil releasability in patients with allergic rhinitis or bronchial asthma. (1990) (57)
Helicobacter pylori Hp(2–20) Promotes Migration and Proliferation of Gastric Epithelial Cells by Interacting with Formyl Peptide Receptors In Vitro and Accelerates Gastric Mucosal Healing In Vivo1 (2009) (56)
Lung mast cells are a source of secreted phospholipases A2. (2009) (56)
Group V Secreted Phospholipase A2 Induces the Release of Proangiogenic and Antiangiogenic Factors by Human Neutrophils (2017) (56)
General anaesthetics induce only histamine release selectively from human mast cells. (1991) (55)
The Immune Landscape of Thyroid Cancer in the Context of Immune Checkpoint Inhibition (2019) (55)
Treatment of mastocytosis: pharmacologic basis and current concepts. (2001) (54)
Arachidonic acid metabolism in inflammatory cells of patients with bronchial asthma (2000) (54)
Protein Fv produced during vital hepatitis is a novel activator of human basophils and mast cells. (1993) (54)
Pathophysiology of human basophils and mast cells in allergic disorders. (1989) (54)
The oncolytic virus dl922-947 reduces IL-8/CXCL8 and MCP-1/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma (2015) (53)
Histamine Release from Mast Cells and Basophils. (2017) (53)
An inhibitor of lipoxygenase inhibits histamine release from human basophils. (1980) (53)
Basophils: historical reflections and perspectives. (2014) (52)
Secretory Phospholipases A2 as Multivalent Mediators of Inflammatory and Allergic Disorders (2003) (52)
Mast cells in rheumatoid arthritis: friends or foes? (2017) (51)
Hydrocortisone and human lymphocytes: increases in cyclic adenosine 3':5'-monophosphate and potentiation of adenylate cyclase-activating agents. (1980) (51)
Metabolic and hemodynamic effects of peptide leukotriene C4 and D4 in man (1997) (51)
In vivo characterization of the anti-inflammatory effect of cyclosporin A on human basophils. (1993) (51)
Modulation of histamine release from human basophils in vitro by physiological concentrations of zinc. (1981) (50)
Models of Heart Failure Based on the Cardiotoxicity of Anticancer Drugs. (2016) (49)
Mast cells in early rheumatoid arthritis associate with disease severity and support B cell autoantibody production (2018) (48)
Human basophil releasability. III. Genetic control of human basophil releasability. (1986) (48)
Omalizumab in patients with eosinophilic granulomatosis with polyangiitis: a 36-month follow-up study (2016) (48)
Effects of histamine on coronary hemodynamics in humans: role of H1 and H2 receptors. (1987) (48)
Ability of Interleukin‐33– and Immune Complex–Triggered Activation of Human Mast Cells to Down‐Regulate Monocyte‐Mediated Immune Responses (2015) (48)
Role of superallergens in allergic disorders. (2007) (47)
Role of superallergens in allergic disorders. (2007) (47)
Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives (2018) (47)
Cardiovascular and Metabolic Effects of Peptide Leukotrienes in Man a (1988) (46)
The clinical relevance of basophil releasability. (1994) (45)
Leptin modulates autophagy in human CD4+CD25− conventional T cells (2014) (45)
Histamine-Induced Activation of Human Lung Macrophages (2001) (45)
Expression and function of Na+/Ca2+ exchangers 1 and 3 in human macrophages and monocytes (2009) (45)
Human mast cells and basophils in HIV-1 infection. (2001) (45)
Elevated plasma levels of vascular permeability factors in C1 inhibitor‐deficient hereditary angioedema (2016) (45)
Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy (1997) (44)
Possible role of phospholipase A2 in triggering histamine secretion from human basophils in vitro. (1981) (44)
Increased erythropoietin production in anephric rats with hyperplasia of the reticuloendothelial system induced by colloidal carbon or zymosan. (1976) (44)
Expression and function of Angiopoietins and their tie receptors in human basophils and mast cells. (2013) (44)
Tumor-Associated Mast Cells in Thyroid Cancer (2015) (44)
Human heart mast cells in anaphylaxis and cardiovascular disease. (1995) (43)
The mechanism of basophil histamine release induced by pepstatin A. (1984) (43)
Histamine receptors and antihistamines: from discovery to clinical applications. (2014) (42)
The role of cyclic AMP in modulating cytotoxic T lymphocytes. II. Sequential changes during culture in responsiveness of cytotoxic lymphocytes to cyclic AMP-active agents. (1983) (41)
Human synovial mast cells. II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. (1997) (40)
IL‐3 synergises with basophil‐derived IL‐4 and IL‐13 to promote the alternative activation of human monocytes (2015) (39)
Innate Immune Modulation by GM-CSF and IL-3 in Health and Disease (2019) (39)
Inhibition of IgE-mediated histamine release from human basophils and mast cells by fenoterol. (1984) (39)
The Proteomic Landscape of Human Ex Vivo Regulatory and Conventional T Cells Reveals Specific Metabolic Requirements (2016) (39)
Cardiac Mast Cells: Underappreciated Immune Cells in Cardiovascular Homeostasis and Disease. (2020) (38)
Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells. (1993) (38)
Recent Advances on Pathophysiology, Diagnostic and Therapeutic Insights in Cardiac Dysfunction Induced by Antineoplastic Drugs (2015) (37)
Evidence for an adenosine A2/Ra receptor on human basophils. (1985) (37)
HIV-1 Envelope gp41 Peptides Promote Migration of Human FcεRI+ Cells and Inhibit IL-13 Synthesis Through Interaction with Formyl Peptide Receptors1 (2002) (37)
Potential involvement of neutrophils in human thyroid cancer (2018) (37)
IgE and IL‐33−mediated triggering of human basophils inhibits TLR4−induced monocyte activation (2014) (37)
Mechanisms of IgE elevation in HIV-1 infection. (2000) (37)
Differences between histamine release from rat mast cells and human basophils and mast cells (1979) (37)
Immune-metabolic profiling of anorexic patients reveals an anti-oxidant and anti-inflammatory phenotype. (2015) (36)
The role of basophils and mast cells in the pathogenesis of pulmonary diseases. (1985) (36)
Human cardiac mast cells in anaphylaxis. (2010) (36)
In situ characterization of mast cells in the frog Rana esculenta (1998) (36)
Human Basophils and Mast Cells: Clinical Aspects (1995) (36)
Neutrophil Extracellular Traps in Cancer. (2021) (35)
Superantigenic Activation of Human Cardiac Mast Cells (2019) (35)
Mechanism of activation of human basophils by Staphylococcus aureus Cowan 1 (1987) (35)
Cyclosporin a inhibits the release of histamine and peptide leukotriene C4 from human lung mast cells (1988) (35)
Immune cells as a source and target of angiogenic and lymphangiogenic factors. (2014) (35)
The immunoglobulin superantigen-binding site of HIV-1 gp120 activates human basophils (2000) (34)
Metabolic Checkpoints in Rheumatoid Arthritis (2020) (34)
Human basophils and mast cells : biological aspects (1995) (34)
Human heart as a shock organ in anaphylaxis (2014) (34)
Mutational Spectrum of the C1 Inhibitor Gene in a Cohort of Italian Patients with Hereditary Angioedema: Description of Nine Novel Mutations (2014) (34)
Inhibition of ischemia-induced phospholipase activation by quinacrine protects jeopardized myocardium in rats with coronary artery occlusion. (1987) (33)
The role of basophils in inflammatory reactions. (1978) (33)
GM-CSF and IL-3 Modulate Human Monocyte TNF-α Production and Renewal in In Vitro Models of Trained Immunity (2017) (32)
Expression of phospholipases A2 in primary human lung macrophages: role of cytosolic phospholipase A2-alpha in arachidonic acid release and platelet activating factor synthesis. (2009) (32)
Dysregulation of the IgE/FcϵRI network in HIV-1 infection (2001) (32)
Activation of human basophils by staphylococcal protein A. I. The role of cyclic AMP, arachidonic acid metabolites, microtubules and microfilaments. (1982) (31)
Immunopharmacology of human mast cells and basophils (1998) (31)
Immunopharmacological modulation of mast cells. (2014) (31)
Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells. (1997) (31)
Upregulation of the N-Formyl Peptide Receptors in Scleroderma Fibroblasts Fosters the Switch to Myofibroblasts (2015) (31)
Basophils and skin disorders. (2014) (31)
Anaplastic Thyroid Cancer Cells Induce the Release of Mitochondrial Extracellular DNA Traps by Viable Neutrophils (2020) (30)
Angiogenesis, lymphangiogenesis and clinical implications (2013) (29)
Eosinophil granule proteins are selective activators of human heart mast cells. (1997) (29)
Protein Fv Produced during Viral Hepatitis Is an Endogenous Immunoglobulin Superantigen Activating Human Heart Mast Cells (2003) (29)
Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens (2016) (28)
Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells (1986) (28)
Immunosuppressive therapy with rituximab in common variable immunodeficiency (2019) (28)
Human basophil/mast cell releasability. VII. Heterogeneity of the effect of adenosine on mediator secretion. (1989) (27)
IgE‐Mediated Basophil Phenomena: Quantitation, Control, Inflammatory Interactions (1978) (27)
Human basophil releasability. VIII. Increased basophil releasability in patients with scleroderma. (1991) (26)
Lactate: Fueling the fire starter (2019) (26)
Role of the hypophysis in erythropoietin production during hypoxia. (1978) (26)
Adenosine receptors on human inflammatory cells. (1984) (26)
The antineoplastic bryostatins affect human basophils and mast cells differently. (1995) (26)
Inhibition of platelet-activating factor synthesis in human neutrophils and platelets by propionyl-L-carnitine. (1999) (26)
Immunological Modulation of Human Cardiac Mast Cells (1999) (26)
Hepatic Erythropoietin: Enhanced Production in Anephric Rats with Hyperplasia of Kupffer Cells (1976) (26)
Mast Cells: Fascinating but Still Elusive after 140 Years from Their Discovery (2020) (25)
Angiogenesis, lymphangiogenesis and atopic dermatitis. (2012) (25)
The Wiskott‐Aldrich syndrome: studies of platelets, basophils and polymorphonuclear leucocytes (1986) (25)
Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells. (1996) (25)
Inhibition of Secretory Phospholipase A2-Induced Cytokine Production in Human Lung Macrophages by Budesonide (2009) (25)
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors (2021) (24)
Erythropoietin production by the liver in fetal-neonatal life. (1975) (24)
Emotional processes and stress in children affected by hereditary angioedema with C1-inhibitor deficiency: a multicenter, prospective study (2018) (24)
Heterogeneity of Liver Disease in Common Variable Immunodeficiency Disorders (2020) (24)
IL-33 and Superantigenic Activation of Human Lung Mast Cells Induce the Release of Angiogenic and Lymphangiogenic Factors (2021) (24)
Inhibition of histamine release from human basophils in vitro by calmodulin antagonists. (1983) (24)
Antiinflammatory effects of oxatomide. (1999) (24)
Role of human FcεRI+ cells in HIV‐1 infection (2001) (24)
The anti-IgE/anti-FcepsilonRIalpha autoantibody network in allergic and autoimmune diseases. (1999) (24)
Mast cells in rheumatic disorders: mastermind or workhorse? (1998) (24)
Adenosine receptors of human leukocytes--II. Characterization of an inhibitory P-site. (1990) (24)
Studies on human basophil releasability. (1985) (24)
Possible role of calmodulin in the control of histamine release from human basophil leukocytes. (1986) (23)
Control mechanisms of human basophil releasability. (1986) (23)
Are Basophils and Mast Cells Masters in HIV Infection? (2016) (23)
Mast cells and basophils in adverse reactions to drugs used during general anesthesia. (1995) (23)
Contrast media are incomplete secretagogues acting on human basophils and mast cells isolated from heart and lung, but not skin tissue (1996) (23)
Biochemical functions of a pool of arachidonic acid associated with triglycerides in human inflammatory cells. (1995) (23)
Cyclic nucleotides in immune responses and allergy. (1980) (23)
Angiogenesis, lymphangiogenesis and clinical implications. Preface. (2014) (22)
Hymenoptera Venom Immunotherapy: Tolerance and Efficacy of an Ultrarush Protocol versus a Rush and a Slow Conventional Protocol (2012) (22)
Independence of iron absorption from the rate of erythropoiesis. (1974) (22)
Novel Autocrine and Paracrine Loops of the Stem Cell Factor/Chymase Network (1999) (22)
Evaluation of vaccination safety in children with mastocytosis (2017) (21)
Is There a Role for Basophils in Cancer? (2020) (21)
Heterogeneous effects of protamine on human mast cells and basophils. (1997) (21)
Successful endoscopic treatment of GI-tract fistulas with a fast-hardening amino acid solution. (1989) (21)
Basophils in Tumor Microenvironment and Surroundings. (2020) (21)
Pharmacological modulation of human mast cells and basophils (2002) (20)
Control mechanisms of mediator release in human basophils and mast cells. (1988) (20)
Helicobacter Pylori HP(2–20) Induces Eosinophil Activation and Accumulation in Superficial Gastric Mucosa and Stimulates VEGF-α and TGF-β Release by Interacting with Formyl-Peptide Receptors (2013) (20)
The Drug Ambassador Project - The diversity of diagnostic procedures for drug allergy around Europe (2005) (20)
Superallergens: a new mechanism of immunologic activation of human basophils and mast cells (2006) (20)
Lipopolysaccharide-Elicited TSLPR Expression Enriches a Functionally Discrete Subset of Human CD14+ CD1c+ Monocytes (2017) (19)
The role of mast cell-derived secreted phospholipases A2 in respiratory allergy. (2010) (19)
Secreted Phospholipases A2 in Hereditary Angioedema With C1-Inhibitor Deficiency (2018) (19)
Control mechanisms of histamine release from human basophils in vitro: the role of phospholipase A2 and of lipoxygenase metabolites. (1981) (19)
Neutrophil Extracellular Traps, Angiogenesis and Cancer (2022) (19)
Are Mast Cells MASTers in HIV-1 Infection? (2001) (19)
Oxidative stress markers are increased in patients with mastocytosis (2015) (19)
Secretory Phospholipase A2: A Putative Mediator of Airway Inflammation (1999) (18)
Home Therapy with Plasma-Derived C1 Inhibitor: A Strategy to Improve Clinical Outcomes and Costs in Hereditary Angioedema (2015) (18)
Human inflammatory disease (1988) (18)
The human heart as a shock organ in anaphylaxis. (2004) (18)
Eosinophils in the Tumor Microenvironment. (2020) (18)
Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1‐associated periodic syndrome (2016) (18)
LPS‐mediated neutrophil VEGF‐A release is modulated by cannabinoid receptor activation (2020) (18)
Modulation of Human Lung Mast Cell Function by the c-kit Receptor Ligand. (1992) (18)
Holistic Approach to Immune Checkpoint Inhibitor-Related Adverse Events (2022) (17)
The European Competence Network on Mastocytosis (2004) (17)
Modulation of mediator release from human basophils and pulmonary mast cells and macrophages by auranofin. (1990) (17)
Metabolism of lipid mediators in human basophils and mast cells. (1995) (17)
Human Cardiac Mast Cells and Their Role in Severe Allergic Reactions (1998) (17)
Differential modulation of mediator release from human basophils and mast cells by mizolastine (2004) (16)
Clinical advances in mastocytosis (1995) (16)
Pharmacovigilating cardiotoxicity of immune checkpoint inhibitors. (2018) (16)
Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions (2021) (16)
Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2 in Ischemic and Non-Ischemic Heart Failure (2020) (16)
Role(s) of formyl-peptide receptors expressed in nasal epithelial cells. (2011) (16)
Possible role of arachidonic acid and of phospholipase A2 in the control of lysosomal enzyme release from human polymorphonuclear leukocytes. (1983) (16)
Endogenous Superallergen Protein Fv Interacts with the VH3 Region of IgE to Induce Cytokine Secretion from Human Basophils (1999) (16)
HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells (2020) (15)
Altered chromatin landscape in circulating T follicular helper and regulatory cells following grass pollen subcutaneous and sublingual immunotherapy (2021) (15)
Basophil's secrets revealed by flow cytometry (2006) (15)
HIV gp120 Induces the Release of Proinflammatory, Angiogenic, and Lymphangiogenic Factors from Human Lung Mast Cells (2020) (15)
High attack frequency in patients with angioedema due to C1-inhibitor deficiency is a major determinant in switching to home therapy: a real-life observational study (2016) (15)
Human eosinophils : biological and clinical aspects (2000) (15)
Human Lung-Resident Macrophages Express and Are Targets of Thymic Stromal Lymphopoietin in the Tumor Microenvironment (2021) (15)
Activation of human mast cells and basophils by general anaesthetic drugs. (1992) (15)
What are human heart mast cells for? (1995) (15)
Cellular subtype expression and activation of CaMKII regulate the fate of atherosclerotic plaque. (2017) (15)
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients. (2019) (15)
Histamine release from human basophils in vitro: effects of age of cell donor. (1983) (14)
Indomethacin, arachidonic acid metabolism and basophil histamine release. (1979) (14)
Adenosine receptors on human inflammatory cells. (1985) (14)
Forskolin inhibits the release of histamine from human basophils and mast cells (1986) (14)
Tacrolimus ointment for atopic dermatitis. (1998) (14)
Role of Erythrogenin from Liver and Spleen in Erythropoietin Production in the Anephric Rat (1973) (14)
Human macrophages and monocytes express functional Na(+)/Ca (2+) exchangers 1 and 3. (2013) (14)
Chemical mediators and the human heart. (1985) (14)
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment (2020) (14)
The European Competence Network on Mastocytosis (ECNM). (2004) (13)
Basophil degranulation in response to IgE ligation is controlled by a distinctive circadian clock in asthma (2020) (13)
Grass pollen immunotherapy alters chromatin landscape in circulating T follicular and regulatory cells. (2020) (12)
Adenosine receptors on human lymphocytes. (1985) (12)
N-Formyl Peptide Receptors Induce Radical Oxygen Production in Fibroblasts Derived From Systemic Sclerosis by Interacting With a Cleaved Form of Urokinase Receptor (2018) (12)
The Interplay between the Immune and the Endocannabinoid Systems in Cancer (2021) (12)
Macrophage-polarizing stimuli differentially modulate the inflammatory profile induced by the secreted phospholipase A2 group IA in human lung macrophages. (2020) (12)
Benzene Metabolites Inhibit the Release of Proinflammatory Mediators and Cytokines from Human Basophils (2010) (12)
Bryostatin 1 enhances lymphokine activated killer sensitivity and modulates the β1 integrin profile of cultured human tumor cells (1995) (12)
Effect Of α2-Adrenergic Agonists And Antagonists On Cytokine Release From Human Lung Macrophages Cultured In Vitro (2016) (12)
Immunopathogenesis of Psoriasis and Pharmacological Perspectives (2009) (11)
Contents, Vol. 76, Supplement 1, 1985 (1985) (11)
IL-3 in the development and function of basophils. (2021) (11)
Immunopathogenesis of Psoriasis and Pharmacological Perspectives (2009) (11)
Validation of Calculated Globulin (CG) as a Screening Test for Antibody Deficiency in an Italian University Hospital. (2018) (11)
Chapter 26 – Human Mast Cells and Basophils in Immune Responses to Infectious Agents (2000) (11)
Immunological interactions between human eosinophils and cardiac mast cells. (2000) (11)
Possible role of calmodulin in human inflammatory reactions. (1983) (11)
Milestones in the biology and pharmacology of histamine H1‐receptor antagonists (1997) (11)
Antiinflammatory effect of FK 506 on human basophils. (1991) (10)
Metabolism of lipid mediators in human eosinophils. (2000) (10)
Nonspecific histamine-releasing properties of general anesthetic drugs (1991) (10)
Functional and biochemical evidence of a specific adenosine A2/Ra receptor on human platelets * (1988) (10)
In vitro effects of ultraviolet A on histamine release from human basophils (2003) (10)
Immunopathogenesis of psoriasis and psoriatic arthritis and pharmacological perspectives. (2011) (10)
Possible role of calmodulin in the control of lysosomal enzyme release from human polymorphonuclear leukocytes. (1984) (10)
Assessing allergenicity of different tomato ecotypes by using pooled sera of allergic subjects: identification of the main allergens (2012) (10)
Immunopathogenesis of psoriasis and psoriatic arthritis and pharmacological perspectives. (2011) (10)
Lipoxygenase products of arachidonic acid: role in modulation of IgE-induced histamine release. (1982) (10)
Histamine and human heart. (1985) (10)
Protein Fv: an endogenous immunoglobulin superantigen and superallergen. (2007) (10)
Dysregulation of the IgE/Fc epsilon RI network in HIV-1 infection. (2001) (9)
Renal Mechanisms Underlying Cyclic AMP Action on Erythropoiesis (1973) (9)
Gastroduodenal Disorders in Patients with CVID Undergoing Immunoglobulin Therapy. (2018) (9)
Modulation of mast cell and basophil functions by benzene metabolites. (2011) (9)
Heterogeneity of human FcεRI-bearing cells (1993) (9)
Primary cell cultures for the personalized therapy in aggressive thyroid cancer of follicular origin. (2020) (9)
Simplexide Induces CD1d-Dependent Cytokine and Chemokine Production from Human Monocytes (2014) (9)
Biology, diagnosis and therapy of mastocytosis. (1995) (9)
Superantigens and superallergens. (2007) (9)
Maitotoxin, a novel activator of mediator release from human basophils, induces large increases in cytosolic calcium resulting in histamine, but not leukotriene C4, release. (1992) (9)
New aspects of glucocorticoid therapy in immunological disorders: Focus on deflazacort: Discussion (1993) (8)
Adenosine receptors on human basophils and lung mast cells. (1986) (8)
Abstracts from the 10th C1-inhibitor deficiency workshop (2017) (8)
Ciclosporin A inhibits mediator release from human FcεRI+ cells by interacting with cyclophilin (1991) (8)
In vitro and in vivo Characterization of the Anti-Inflammatory Effects of Cyclosporin A. (1992) (8)
Davos declaration: Allergy as a global problem (Allergy: European Journal of Allergy and Clinical Immunology (2012) 67, (141-143)) (2012) (8)
The role of adenosine in the control of immune function (1980) (8)
Adenosine receptors on human leukocytes IV. characterization of an A1/Ri receptor (1992) (8)
Erythroid colony formation and erythropoietin activity in mice treated with estradiol benzoate. (1977) (8)
Hereditary angioedema attack: what happens to vasoactive mediators? (2019) (7)
IgE-mediated activation of human heartin vitro (1986) (7)
A Unique Case of Angioedema With Anti-C1 Inhibitor Antibodies and Normal C1 Inhibitor Levels. (2016) (7)
Progress in clinical immunology. The role of chemical mediators and cellular interactions. 14th Symposium of the Collegium Internationale Allergologicum, Sorrento, October 10-14, 1982. (1983) (7)
Erythropoietin production in the rat: additive role of kidney and liver. (1976) (7)
Heterogeneity of human mast cells and basophils (1988) (7)
IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells (2022) (7)
8. Adenosine-adenosine deaminase modulation of histamine release (1978) (7)
The releasability of lysosomal enzymes from neutrophil leukocytes in patients with rheumatoid arthritis. (1996) (7)
Arachidonic acid remodeling in human inflammatory cells migrating to the lung in vivo. (1997) (7)
Inhibition of histamine release from human FcεRI+ cells by nimesulide (1992) (6)
Differential Effects of Alarmins on Human and Mouse Basophils (2022) (6)
The role of mast cell and basophil activation in human allergic reactions. (1989) (6)
Superallergens: a novel mechanism of IgE-mediated activation of human basophils and mast cells (2004) (6)
How can we manage the cardiac toxicity of immune checkpoint inhibitors? (2021) (6)
Novel Biological Therapies in Severe Asthma: Targeting the Right Trait. (2019) (6)
275 Efficacy of Omalizumab in the Treatment of Urticaria-Vasculitis Associated to Churg-Strauss Syndrome: A Case Report (2012) (6)
Immunologic and non-immunologic release of histamine and tryptase from human heart mast cells (1995) (6)
Mepindolol Reduces Myocardial Necrosis in Rats with Coronary Artery Occlusion (1985) (6)
Novel Biological Therapies in Severe Asthma: Targeting the Right Trait. (2019) (6)
Livedo reticularis and congenital hypogammaglobulinemia. (1992) (6)
Modulation of the release of histamine and arachidonic acid metabolites from human basophils and mast cells by auranofin (1986) (5)
Altered Metabolism of Phospholipases, Diacylglycerols, Endocannabinoids, and N-Acylethanolamines in Patients with Mastocytosis (2019) (5)
Activation of human basophils by bacterial products. (1985) (5)
Adenosine-adenosine deaminase modulation of histamine release from human basophilsin vitro (1979) (5)
Anti-inflammatory effects of glucocorticoids and cyclosporin A on human basophils (2005) (5)
Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions (2022) (5)
Hp(2-20) peptide of Helicobacter pylori and the innate immune receptors: specific role(s) of the formyl peptide receptors. (2012) (5)
Proteomic Analysis of Sera from Common Variable Immunodeficiency Patients Undergoing Replacement Intravenous Immunoglobulin Therapy (2011) (5)
Heterogeneity of Mediator Release From Human Basophils and Mast-cells Induced By Contrast-media (cm) (1994) (4)
Immunofluorescence localization of calmodulin in human polymorphonuclear leukocytes. (1983) (4)
Prophylactic treatment with plasma‐derived C1 inhibitor in idiopathic non‐histaminergic angioedema (2016) (4)
Hereditary angioedema: the plasma contact system out of control: comment (2018) (4)
Lung involvement in rheumatoid arthritis. (2003) (4)
8-Methoxypsoralen and long-wave ultraviolet A inhibit the release of proinflammatory mediators and cytokines from human Fc epsilon RI+ cells: an in vitro study. (2003) (4)
22 Modulation of histamine release from human basophils by calmodulin antagonists (1983) (4)
Chapter 36 – Chemokine Receptors on Human Mast Cells (2000) (4)
Human mast cells adhere to extracellular matrix proteins through their selective expression of beta 1 integrins. (1995) (3)
Heterogeneity of human Fc epsilon RI-bearing cells. (1993) (3)
Modulation of Mediator Release From Human FcεRI + Cells (1992) (3)
Asthma and allergic diseases (2015) (3)
Abnormalities of Thyroid Function in Sjogren’s Syndrome (1987) (3)
Laura Cardiomyopathy Stem Cell Factor in Mast Cells and Increased Mast Cell Density in Idiopathic and Ischemic (1998) (3)
Chapter 33 – Lipid Mediators from Mast Cells and Basophils in Allergic Diseases (2000) (3)
Immunologic characterization of human heart mast cells (1994) (3)
Selective activation of human mast cells by general anesthetics (1992) (3)
Anti-Inflammatory Effect of Deflazacort. (1992) (3)
Modulation of cyclic AMP in human leukocytes by physiological doses of adenosine (1978) (3)
The Role of Omalizumab in Patients With Eosinophilic Granulomatosis With Polyangiitis (Churg‐Strauss): Comment on the Article by Jachiet et al (2017) (3)
Ciclosporin A inhibits mediator release from human Fc epsilon RI+ cells by interacting with cyclophilin. (1991) (3)
Histamine H1‐receptor‐mediated release of preformed mediators and cytokines and airway remodelling (2002) (3)
Role of Human Heart Mast Cells in Immunologic and Inflammatory Mechanisms Underlying Cardiovascular Disorders (2003) (2)
Milestones in the biology and pharmacology of H1-receptor antagonists. (1997) (2)
Gender dimorphism in IgA subclasses in T2-high asthma (2022) (2)
Reply (2016) (2)
Mechanisms underlying pulmonary hypertension by hypoxemia. (1984) (2)
Release of chemical mediators from rabbit hearts (1987) (2)
Angiopoietins, vascular endothelial growth factors and secretory phospholipase A2 in heart failure patients with preserved ejection fraction. (2022) (2)
Physiological concentrations of zinc inhibit the release of histamine from human basophils and lung mast cells (2005) (2)
Basophils from allergy to cancer (2022) (2)
Non-invasive assessment of electrophysiological effects of histamine infusion in mam (1985) (2)
Histamine release from human basophils by pepstatin A (1985) (2)
Immunodeficiency and Multiple Primary Malignancies (2009) (2)
Modulation of β-adrenergic receptor by hydrocortisone in human polymorphonuclear leukocytes (1982) (2)
[Leukotrienes and histamine in anesthesia]. (1988) (2)
Remodelling of Arachidonic Acid Pools in Inflammatory Cells Migrating into the Lung (1998) (1)
Activation of human basophils byStaphylococcus aureus Cowan I. II. Alternative F(ab′)-mediated mechanism (1985) (1)
Betamethasone modulates the biological function of human polymorphonuclear leukocytes. (1987) (1)
H. PYLORI PEPTIDE Hp(2-20) AND HEALING OF INJURED GASTRIC MUCOSA: ROLE OF FORMYL-PEPTIDE RECEPTORS (2009) (1)
Desensitization (ds) to cyclic amp (camp) - active agents during culture of cytotoxic t lymphocytes (ctl). Abstr. (1979) (1)
Non-invasive assessment of electrophysiological effects of histamine infusion in man. (1985) (1)
Hereditary angiooedema and psychological stress: an exploratory study (2015) (1)
Severe Aortic Valve Regurgitation in Relapsing Polychondritis. (2017) (1)
Remodeling of arachidonic acid in inflammatory cells of the human lung (2004) (1)
Sources of Arachidonic Acid in Human Lung Macrophages. (1992) (1)
Selective Functions in Human Eosinophils Activate 2 Secretory Phospholipases A (2003) (1)
Human Lung Mast Cells: Therapeutic Implications in Asthma (2022) (1)
Differences between antigen and anti immuno globulin e induced basophil histamine release (1979) (1)
SARS-CoV-2 Spike Protein Activates Human Lung Macrophages (2023) (1)
Specific and novel aspects of histamine H[1]-receptor antagonists (1997) (1)
Contents, Vol. 94, 1991 (1991) (1)
XXVIII Congress of the European Academy of Allergy and Clinical Immunology (EAACI) (2009) (1)
Serum levels of tryptase suggest that mast cells might play an anti‐inflammatory functions in Rheumatoid Arthritis (2015) (1)
Are the anti-allergic properties of H1-antihistamines of any clinical relevance? (2000) (1)
Human Mast Cells, Basophils and Their Mediators (1992) (1)
Modulation of mediator release from human inflammatory cells (1986) (1)
FRI0035 Expression and functions of vascular endothelial growth factor and angiopoietin receptors in human synovial mast cells (2013) (1)
Role of basophils in airways inflammation (2000) (0)
Autoantibodies to IgE can induce the release of proinflammatory and vasoactive mediators from human cardiac mast cells (2022) (0)
Abstract SY06-01: Tumor-associated myelomonocytic cells as therapeutic targets (2017) (0)
Acknowledgement to the Reviewers (2015) (0)
The Italian federation of immunological societies (2000) (0)
Neutrophils Involvement in Human Thyroid Cancer (2018) (0)
FRI0036 Meta-Immunological Profiling of Patients with Behçet's Disease Reveals Novel Biomarkers of Disease Activity, Progression and Response To Therapy (2016) (0)
Italian immunology well but hoping to do better (2001) (0)
ACTIVATION OF HUMAN MAST CELLS TO DOWN- REGULATE MONOCYTE-MEDIATED IMMUNE RESPONSES Chapter 6 (2016) (0)
Identification and characterization of anti-caries natural compounds and their use in experimental slow release tablets as advancement of oral health strategies (2018) (0)
Contents, Vol. 66, Supplement 1, 1981 (1981) (0)
669 H. pylori Peptide HP(2-20) Promotes Healing of Injured Gastric Mucosa By Interacting with Formyl-Peptyde Receptors (2009) (0)
Title Pages / Table of Contents (1995) (0)
ReceptorMacrophages Expressing the M-Type in Human Lung 2 Secreted Phospholipase A Activation of Cytokine Production by (2004) (0)
Dedication / Contents / Preface (2007) (0)
Contents, Vol. 99, 1992 (1992) (0)
Immunopharmacology of inflammation: Modulation of the release of chemical mediators from human inflammatory cells by auranofin (1985) (0)
Contents, Vol. 99, 1992 (1992) (0)
2 A Phospholipases and Group X Secreted Macrophages Induced by Group IIA Growth Factors from Human Lung Production of Vascular Endothelial (2010) (0)
FRI0043 Synovial Mast Cells Correlate with Local and Systemic Inflammation and Are Functionally Associated with Ectopic Lymphoid Structures in Patients with Early Rheumatoid Arthritis (2016) (0)
Does the Most Potent Antihistamine Also Have the Strongest Antiinflammatory Effect (2005) (0)
Inhibition of Cytosolic Phospholipase A2 in Human Neutrophils by Oxatomide (2001) (0)
Front & Back Matter (2013) (0)
VI. Changes in Basophil Releasability in Patients with Allergic Rhinitis or Bronchial Asthma 1 - 3 (1990) (0)
Subject Index Vol. 151, 2010 (2010) (0)
Effects of histamine H1-receptor stimulation on coronary hemodynamics in man (1985) (0)
Front & Back Matter (2014) (0)
In Honour of Paul Kallós (1987) (0)
Hereditary Angioedema with Normal C1 Inhibitor: An Italian Case Series (2017) (0)
Front & Back Matter (2013) (0)
From Molecular Science to the Treatment of Allergy (1999) (0)
Contents Vol. 171, 2016 (2017) (0)
Chemical Mediators and Cellular Interactions in Clinical Immunology: 19th Symposium, Collegium Internationale Allergologicum (CIA), Capri, May 1992 (1993) (0)
Gianni Marone SPECIFIC INVOLVEMENT OF CONVENTIONAL AND REGULATORY CD 4 + T CELLS IN TUMOR NECROSIS FACTOR RECEPTOR-ASSOCIATED PERIODIC SYNDROME ( TRAPS ) (2017) (0)
2 Phospholipases A Induced by Group IIA and Group X Secreted Factors from Human Lung Macrophages Production of Vascular Endothelial Growth (2010) (0)
VASOSPASM Elfect of activation of the H 1 receptor on coronary hemodynamics in man (2005) (0)
Interplay between C1-inhibitor and group IIA secreted phospholipase A2 impairs their respective function (2022) (0)
Contents, Vol. 82, 1987 (1987) (0)
3 Region of IgE H Interaction with the V Cells Through + RI e from Human Fc HIV-1 gp120 Induces IL-4 and IL-13 Release (1999) (0)
Phospholipase and Ischemic Damage: Possibilities of Interventions (1984) (0)
Envelope gp120 of HIV-1 binds to and activates human basophils (2001) (0)
Title Page / Contents / Preface (1995) (0)
招請講演 Human Mast Cells, Basophils and Macrophages Modulate Angiogenesis and Lymphangiogenesis (第59回日本アレルギー学会秋季学術大会号) (2009) (0)
Italian Society for Allergology and Clinical Immunology (2004) (0)
ANTI-INFLAMMATORY ACTIVITY OF ANTIHISTAMINES * — (2004) (0)
410 IgE-mediated activation of human FcϵRI+ cells by protein L (PL) (1991) (0)
Basophils: Biological Properties and Role in Allergic Diseases (2009) (0)
Chapter 42 – Antihistaminic and Anti-inflammatory Effects of Mizolastine (2000) (0)
Contents Vol. 132, 2003 (2003) (0)
General discussion III (2004) (0)
[The role of primary chemical mediators in anaphylactic and inflammatory reactions]. (1982) (0)
Heterogeneity of the effects of radiocontrast media on mediator release from human mast cells and basophils (2012) (0)
IgG anti IgE in atopic dermatitis. (1989) (0)
Calmodulin and Human Inflammatory Reactions (1984) (0)
Basophils beyond allergic and parasitic diseases (2023) (0)
[Demonstration of 2 experimental models of pure chronic erythroblastopenia]. (1975) (0)
P21 - Evaluation of modifications in SCORMA Index and grading in the follow-up of a pediatric population with mastocytosis (2014) (0)
Respiratory allergy : advances in clinical immunology and pulmonary medicine : proceedings of the III International Meeting on Respiratory Allergy, Naples, 1-4 April 1992 (1993) (0)
Chapter 37 – Release and Cleavage of Stem Cell Factor by Human Mast Cells (2000) (0)
Immunopharmacology of Inflammation (1985) (0)
Targeting Siglec 8 for Asthma and Mast Cell Disorders (2018) (0)
Receptors in Human Basophils Endothelial Growth Factors and Their Expression and Functions of the Vascular (2012) (0)
Recent advances in understanding basophil functions in vivo (2018) (0)
Impact of radiotherapy performed after chemotherapy on heart function in Hodgkin’s and non-Hodgkin’s adult lymphoma patients (2020) (0)
CURRICULUM IN HUMAN DEVELOPMENT AND GROWTH (2017) (0)
Session 1. Environmental factors in allergic disorders (2004) (0)
FRT – FONDATION RENE TOURAINE (2015) (0)
Contents Vol. 166, 2015 (2015) (0)
Subject Index Vol. 132, 2003 (2003) (0)
Chapter 6 Immunodeficiency and Multiple Primary Malignancies (0)
UNFOLDED PROTEIN RESPONSE SIGNALING PATHWAY REGULATES CARDIAC FUNCTION (2017) (0)
History of the Collegium Internationale Allergologicum: A Very Special Society Devoted to Allergy and Immunology (2021) (0)
Front & Back Matter (2014) (0)
ADENOSINE RECEPTORS ON HUMAN BASOPHILS AND LUNG MAST CELLS: 122 (1985) (0)
Role of Formyl-Peptide Receptors in Chronic Rhinosinusitis (2010) (0)
Neutrophil Extracellular Traps in Asthma: Friends or Foes? (2022) (0)
Antiapoptotic Seminal Vesicle Protein IV Induces Histamine Release from Human FcεRI+ Cells (2009) (0)
IS3-3 Activation of Human Macrophages by Secreted Phospholipases A_2(Session 3: Activation and signaling in inflammatory cells,Eosinophils, other Inflammatory Cells and Molecules in Allergy) (2009) (0)
of Birmingham Neuro-endocrine networks controlling immune system in health and disease (2014) (0)
Session 2. Genetic factors and immune tolerance in allergic disorders (2004) (0)
The role of interleukin-36 in inflammatory skin diseases (2017) (0)
Session 3. Immune cells in allergic disorders (2004) (0)
Subject Index, Vol. 106, 1995 (1995) (0)
Contents, Vol. 106, 1995 (2004) (0)
Expression on Human Fc Migration and Up-Regulates CCR3 -Chemokine Homolog That Promotes β Tat Protein Is an HIV-1-Encoded (2012) (0)
Angiogenesis, s and Clinical Implications (2015) (0)
Contents Vol. 151, 2010 (2010) (0)
Correction to: Is there a role for microbiome‑based approach in common variable immunodeficiency? (2023) (0)
[Adhesiveness and aggregation of platelets in rats exposed to 6 ATA of oxygen]. (1969) (0)
[Hyperbaric oxygen and coronary dilator agents in experimental necrosis of the myocardium in rats]. (1975) (0)
Roles of mast cells and their mediators in human thyroid carcinomas (2007) (0)
Receptor-Like 1 and -Like 2 Is an Endogenous Ligand for Formyl Peptide through a Urokinase Receptor Epitope That Urokinase Induces Basophil Chemotaxis (2004) (0)
[Cardiovascular effects of histamine infusion in humans]. (1981) (0)
Cost-minimization of innovative C1-inhibitor self-administration strategies in Hereditary Angioedema (2014) (0)
[Behavior of NEFA and blood sugar levels in rats exposed to hyperbaric oxygenation]. (1968) (0)
OC.02.2 ROLE OF EOSINOPHILS IN THE REPAIR OF H. PYLORI-INFECTED GASTRIC MUCOSA IN HUMANS AND IN HP(2–20)-MEDIATED GASTRIC MUCOSAL HEALING IN THE RAT (2013) (0)
University of Birmingham Metabolic checkpoints in rheumatoid arthritis (2020) (0)
Macrophages (PP-047) (2010) (0)
FRI0030 Synovial mast cells identify patients with a severe phenotype in a cohort of dmard naÏve patients with early rheumatoid arthritis (2017) (0)
Variations in blood chemistry produced by cell free spleen homogenate in dogs subjected to experimental myo cardial infarction (1968) (0)
Expression and function of the uPA-uPAR system and the FMLP receptor family in human basophils (2004) (0)
Title Page / Contents / Contents of Volume 61 ‘Human Basophils and Mast Cells: Biological Aspects’ / Preface (1995) (0)
[Sulpiride and intestinal motility]. (1975) (0)
THU0024 Human Mast Cells Stimulated with IL-33 and Immune Complexes Down-Regulate Monocyte Activation in Rheumatoid Arthritis (2015) (0)
[Hyperbaric oxygenation in normal and splenectomized rats]. (1969) (0)
Contents, Vol. 74, 1984 (1984) (0)
ADENOSINE RECEPTORS ON HUMAN LYMPHOCYTES: 123 (1985) (0)
Is there a role for microbiome-based approach in common variable immunodeficiency? (2023) (0)
[Influence of several drugs on intestinal motility]. (1975) (0)
Betamethasone increases the β-adrenergic receptor density of human polymorphonuclear leukocytes (1985) (0)
[Survival and reticulocyte count in mice, exposed to 4 ATA of O 2 , treated with spleen homogenate]. (1970) (0)
[Relations between hyperbaric oxygenation and coagulation]. (1970) (0)
Heterogeneity of human basophils and mast cells in response to muscle relaxants (1992) (0)
[Acute hyperbaric oxygenation. Effects on plasmatic K+ and N+ and on GOT and GPT transaminases in rats exposed to 3 absolute atmospheres of oxygen]. (1969) (0)
Livedo reticularis in a patient with systemic lupus erythematosus and anticardiolipin antibodies (1993) (0)
[Relations between hyperbaric oxygenation and coagulation in splenectomized rats]. (1970) (0)
Biographical Sketch of Dr. Alec H. Sehon (1991) (0)
Discussuion Session 4. 'Evergreen' mediators in asthma (2004) (0)
[Action of sulpiride on intestinal motility]. (1974) (0)
Immunopharmacological heterogeneity of human basophils and mast cells (1990) (0)
Increased cardiac mast cell density and mediator release in patients with dilated cardiomyopathy. (1997) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Gianni Marone?

Gianni Marone is affiliated with the following schools:

Gianni Marone's Academic­Influence.com Rankings

Gianni Marone's Degrees

Similar Degrees You Can Earn

Why Is Gianni Marone Influential?

Gianni Marone's Published Works

Published Works

What Schools Are Affiliated With Gianni Marone?

Gianni Marone's AcademicInfluence.com Rankings